|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
R
R-Max foamboard, 2004, Vol. 18(4) pp. 7
R-THBP (tetrahydrobiopterin)
Japanese tests, 1987, Vol. 01(4) pp. 6; 1990, Vol. 04(4) pp. 1; 1995, Vol. 09(3) pp. 4.
Rett's and other neurological disorders, 1989, Vol. 03(2) pp. 4
serotonin and, 1987, Vol. 01(4) pp. 6; 1989, Vol. 03(2) pp. 4; 1997, Vol. 11(4) pp. 4.
for social relations, 1990, Vol. 04(4) pp. 1; 1997, Vol. 11(4) pp. 4.
Swedish tests, 1997, Vol. 11(4) pp. 4
rabbit syndrome, 1995, Vol. 09(2) pp. 4
Radwany, Steven M., 1995, Vol. 09(2) pp. 4
Rae, Caroline, 2003, Vol. 17(3) pp. 4
rage reduction therapy, 1987, Vol. 01(3) pp. 3
rages, 1993, Vol. 07(3) pp. 7; 1993, Vol. 07(4) pp. 1; 1996, Vol. 10(3) pp. 6; 2000, Vol. 14(1) pp. 7; 2002, Vol. 16(2) pp. 7; 2002, Vol. 16(4) pp. 4. See also aggression, tantrums
Rain Man (movie), 1988, Vol. 02(3) pp. 3; 1989, Vol. 03(1) pp. 1; 1990, Vol. 04(4) pp. 3; 1995, Vol. 09(2) pp. 3; 1995, Vol. 09(3) pp. 3; 2002, Vol. 16(2) pp. 3.
Rainey, L., 1999, Vol. 13(3) pp. 5
Rajik, Alenka, 1989, Vol. 03(2) pp. 5
Rall, W., 1992, Vol. 06(2) pp. 4
Ramsay, Eugene, 1993, Vol. 07(4) pp. 5
Ramsey, Sally, 2000, Vol. 14(3) pp. 6
Randi, the Magician, 1992, Vol. 06(3) pp. 1
Rankin, Diane, 1994, Vol. 08(4) pp. 2
"rapid neuroleptization," 1994, Vol. 08(1) pp. 1
Rapp, Doris, 1998, Vol. 12(1) pp. 3
Rasmussen, Peder, 1994, Vol. 08(2) pp. 4
rat studies, 1989, Vol. 03(1) pp. 4
Ratey, John J., 1987, Vol. 01(3) pp. 4; 1990, Vol. 04(3) pp. 7.
Ratner, R. S., 1998, Vol. 12(2) pp. 7
Rauch, Scott L., 1995, Vol. 09(2) pp. 1–2
Ravel, Guillaume, 2004, Vol. 18(2) pp. 5
Raymond (Rain Man), 1989, Vol. 03(1) pp. 3
reactive follicular hyperplasia, 2000, Vol. 14(4) pp. 2
reading. See education
Realmuto, George, 1987, Vol. 01(3) pp. 2; 1990, Vol. 04(3) pp. 7; 1991, Vol. 05(4) pp. 4; 1996, Vol. 10(1) pp. 4.
Reap, E.A., 1997, Vol. 11(3) pp. 6
Rebec, George V., 1988, Vol. 02(3) pp. 4
recovered autistic children, 2004, Vol. 18(3) pp. 1
rectal digging, 2004, Vol. 18(3) pp. 5
recurrence rate of autism, 1989, Vol. 03(4) pp. 5
Redefer, Laurel A., 1989, Vol. 03(4) pp. 2
Redux. See fenfluramine
Redwood, Lyn, 2000, Vol. 14(3) pp. 2; 2000, Vol. 14(4) pp. 3; 2001, Vol. 15(3) pp. 2.
Reed, Carolyn and Les, 1994, Vol. 08(1) pp. 6
reelin gene variant, 2001, Vol. 15(2) pp. 1; 2003, Vol. 17(2) pp. 2.
reflux esophagitis, 1999, Vol. 13(4) pp. 7
refrigerator mothers, 1990, Vol. 04(2) pp. 1
Refrigerator Mothers (documentary, dir. Hanley), 2002, Vol. 16(1) pp. 7
Regan, A., 1997, Vol. 11(1) pp. 2
registry of clinical drug trials, 2004, Vol. 18(3) pp. 4; 2004, Vol. 18(4) pp. 4.
regressive autism, 2002, Vol. 16(2) pp. 1
Reichelt, Karl L.
award, 2004, Vol. 18(1) pp. 6
on dietary interventions, 1997, Vol. 11(2) pp. 3; 1999, Vol. 13(2) pp. 6; 2002, Vol. 16(3) pp. 1.
on peptidase defects, 1991, Vol. 05(4) pp. 2; 1993, Vol. 07(1) pp. 4.
peptide subtypes, 1987, Vol. 01(2) pp. 4; 1992, Vol. 06(1) pp. 7.
Reid, Greg, 1994, Vol. 08(1) pp. 5
reinforcement deficits, 1987, Vol. 01(4) pp. 5
reinforcing incompatible behaviors, 1989, Vol. 03(1) pp. 5; 1994, Vol. 08(4) pp. 5; 1995, Vol. 09(1) pp. 5.
Reisman, Judith, 1995, Vol. 09(1) pp. 6
Reiss, Allan L., 1988, Vol. 02(4) pp. 1; 1992, Vol. 06(3) pp. 4.
relaxation techniques, 1996, Vol. 10(1) pp. 7
Rembrand, Eve, 1994, Vol. 08(3) pp. 6
Remeron (mirtrazapine), 2004, Vol. 18(1) pp. 9; 2004, Vol. 18(3) pp. 6.
Reminyl (galantamine), 2002, Vol. 16(4) pp. 5
Rennie, Drummond, 2004, Vol. 18(3) pp. 4
repetitive behaviors
drugs (clomipramine) for, 1998, Vol. 12(1) pp. 4
drugs (oxytocin) for, 2002, Vol. 16(4) pp. 5
drugs (risperidone) for, 1997, Vol. 11(2) pp. 6; 1998, Vol. 12(3) pp. 1.
drugs (sertraline) for, 1996, Vol. 10(4) pp. 2; 1998, Vol. 12(2) pp. 4.
drugs (venlafaxine) for, 2000, Vol. 14(2) pp. 4
Epson salt baths for, 2001, Vol. 15(3) pp. 6
strep and, 1999, Vol. 13(1) pp. 5
supplements for, 2001, Vol. 15(3) pp. 6
Repligen, 1999, Vol. 13(3) pp. 2; 1999, Vol. 13(4) pp. 3; 2000, Vol. 14(1) pp. 7; 2001, Vol. 15(2) pp. 1; 2001, Vol. 15(3) pp. 4; 2001, Vol. 15(4) pp. 1; 2002, Vol. 16(2) pp. 2; 2002, Vol. 16(4) pp. 4.
Repp, Alan C., 1988, Vol. 02(3) pp. 2; 1991, Vol. 05(2) pp. 7.
Research and Rehabilitation Training Center on Community-Referenced, Non-Aversive Behavior Management, 1988, Vol. 02(3) pp. 2, 6, 8
residential care. See community residential care, deinstitutionalization, group homes
Resnick Michael, 1995, Vol. 09(4) pp. 1
resource guides
DAN! physicians, 1999, Vol. 13(2) pp. 6; 2000, Vol. 14(1) pp. 2; 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(1) pp. 4.
schools and services, 1997, Vol. 11(2) pp. 4; 1999, Vol. 13(2) pp. 6; 2000, Vol. 14(1) pp. 2; 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(1) pp. 4.
respiratory dyskinesia, 1995, Vol. 09(2) pp. 4
restlessness, 1999, Vol. 13(3) pp. 4
restraints, 2000, Vol. 14(2) pp. 5
reticular activating system, 1988, Vol. 02(2) pp. 5; 1988, Vol. 02(4) pp. 4; 1994, Vol. 08(2) pp. 7.
retinal abnormalities, 1987, Vol. 01(1) pp. 4; 1989, Vol. 03(3) pp. 4.
retinoblastoma, 1989, Vol. 03(1) pp. 4
retrolental fibroplasia, 1989, Vol. 03(1) pp. 1; 1990, Vol. 04(1) pp. 4.
Rett, Andreas, 1997, Vol. 11(3) pp. 7
Rett Syndrome
and autism compared, 1987, Vol. 01(3) pp. 7
and beta-endorphins, 1989, Vol. 03(3) pp. 7
biotin deficiency, 1987, Vol. 01(2) pp. 7
brain abnormalities, 1987, Vol. 01(2) pp. 7; 1988, Vol. 02(1) pp. 4; 1989, Vol. 03(2) pp. 4; 1989, Vol. 03(4) pp. 4; 1994, Vol. 08(4) pp. 4; 1996, Vol. 10(1) pp. 2.
co-morbid conditions, 1991, Vol. 05(2) pp. 4
drugs (bromacriptine) for, 1987, Vol. 01(2) pp. 6; 1988, Vol. 02(3) pp. 4; 1990, Vol. 04(4) pp. 4; 1991, Vol. 05(1) pp. 7; 1996, Vol. 10(1) pp. 2.
drugs (growth regulators) for, 1989, Vol. 03(3) pp. 7
drugs (lamotrigine) for, 1998, Vol. 12(2) pp. 5
drugs (naltrexone) for, 1992, Vol. 06(1) pp. 2
early intervention for, 1996, Vol. 10(1) pp. 2
EEG findings, 1988, Vol. 02(2) pp. 4
genetic factors, 1999, Vol. 13(1) pp. 6; 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(1) pp. 5; 2001, Vol. 15(2) pp. 5.
incidence of, 1996, Vol. 10(1) pp. 2
International Association of, 1999, Vol. 13(1) pp. 6
L-carnitine for, 1996, Vol. 10(3) pp. 4; 1999, Vol. 13(2) pp. 4.
males with symptoms, 1989, Vol. 03(1) pp. 4; 1990, Vol. 04(3) pp. 5; 1991, Vol. 05(2) pp. 4; 1991, Vol. 05(3) pp. 4.
muscle mitochondrial changes in, 1989, Vol. 03(4) pp. 4; 1990, Vol. 04(1) pp. 4; 1991, Vol. 05(3) pp. 5.
neurotransmitters in, 1988, Vol. 02(1) pp. 4; 1990, Vol. 04(4) pp. 4; 1994, Vol. 08(4) pp. 4.
and Parkinson's, 1989, Vol. 03(3) pp. 7
as PDD cause, 1999, Vol. 13(1) pp. 6
population study in Italy, 1988, Vol. 02(4) pp. 4
pre-regression abnormalities, 1988, Vol. 02(4) pp. 4
splints for, 1990, Vol. 04(3) pp. 5
supplements for, 1995, Vol. 09(4) pp. 6; 1999, Vol. 13(4) pp. 6; 2001, Vol. 15(4) pp. 3.
symptoms, 1987, Vol. 01(2) pp. 6; 1996, Vol. 10(1) pp. 2; 1997, Vol. 11(3) pp. 7.
toxic exposure and, 1990, Vol. 04(4) pp. 6
treatment, 1987, Vol. 01(2) pp. 6
Rett Syndrome Association, 1987, Vol. 01(2) pp. 6
Rett Syndrome Handbook (Hunter), 1999, Vol. 13(1) pp. 6
Reveley, M. A., 1998, Vol. 12(2) pp. 1
rewards, 1987, Vol. 01(1) pp. 5; 1991, Vol. 05(1) pp. 5; 1991, Vol. 05(4) pp. 5; 1993, Vol. 07(2) pp. 5.
Reynierse, Peter J., 1999, Vol. 13(2) pp. 7
Reynolds, Shelley, 2000, Vol. 14(3) pp. 7
Reznek, Karen, 1993, Vol. 07(2) pp. 6
rheumatoid arthritis, 1995, Vol. 09(1) pp. 7
Rhodes, Melissa C., 2004, Vol. 18(3) pp. 6
RhoGam shots, 2003, Vol. 17(1) pp. 7
Ricaurte, George, 1996, Vol. 10(3) pp. 4; 1997, Vol. 11(1) pp. 5.
Rice, Marylynne, 1989, Vol. 03(4) pp. 7
Rich, Michael W., 1995, Vol. 09(2) pp. 4
Richard, Jacques, 1991, Vol. 05(1) pp. 4
Richardson, ___, 1992, Vol. 06(1) pp. 6
Richardson, Alexandra J., 2002, Vol. 16(1) pp. 4
Richardson, Bill (Representative, NM), 1992, Vol. 06(3) pp. 2; 1993, Vol. 07(2) pp. 1; 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 1; 1994, Vol. 08(2) pp. 2.
Richardson, Mary Ann, 2003, Vol. 17(3) pp. 6
Ricketts, Robert W., 1993, Vol. 07(3) pp. 2
Riddle, Mark, 1995, Vol. 09(4) pp. 4
Riedel, Michael, 2000, Vol. 14(2) pp. 4
right hemisphere damage, 1988, Vol. 02(2) pp. 7; 1995, Vol. 09(4) pp. 5.
right to the most effective treatment, 1988, Vol. 02(3) pp. 6
Rimactane, 1996, Vol. 10(3) pp. 4
Rimland, Bernard
AIT experimental evaluation, 1992, Vol. 06(2) pp. 1; 1994, Vol. 08(2) pp. 6.
Autism Society of America, 36th conference, keynote address for, 2001, Vol. 15(3) pp. 3
Autism Treatment Evaluation Checklist (ATEC), 1999, Vol. 13(4) pp. 2
autosomal recessive model of autism, 1997, Vol. 11(2) pp. 3
awards, 1995, Vol. 09(2) pp. 3
on biological origins of autism, 1997, Vol. 11(2) pp. 3
on co-morbid mental illness, 1998, Vol. 12(2) pp. 3
E-2 form, 1993, Vol. 07(2) pp. 3
ENZYMAID study, 2002, Vol. 16(2) pp. 4
family prevalence studies, 1989, Vol. 03(2) pp. 1; 1989, Vol. 03(4) pp. 5.
on fidelity versus breadth, 1989, Vol. 03(1) pp. 3
"good" gene excess in autism, 1993, Vol. 07(1) pp. 5
on infantile autism, 1994, Vol. 08(1) pp. 3; 1996, Vol. 10(1) pp. 1; 2003, Vol. 17(4) pp. 3.
on Institute of Medicine's MMR report, 2001, Vol. 15(3) pp. 1
keynote address for Autism Society of America, 36th conference, 2001, Vol. 15(3) pp. 3
letter to Mark McClelland (FDA Commissioner), 2003, Vol. 17(2) pp. 3
on mechanical support for facilitated communication, 1998, Vol. 12(2) pp. 2
on MMR and autism, 2003, Vol. 17(3) pp. 3
on pentoxifylline for autism, 1997, Vol. 11(1) pp. 1
on psychogenic theory of autism, 1989, Vol. 03(3) pp. 3
on savants, 1989, Vol. 03(1) pp. 1–2
on strabismus in autistics, 1999, Vol. 13(3) pp. 6
twin studies, 1989, Vol. 03(2) pp. 1
Rimland, Ingrid, 1989, Vol. 03(4) pp. 7
Rimland, Mark
Rincover, Arnold, 1987, Vol. 01(1) pp. 5
rings, 1990, Vol. 04(4) pp. 5
Riordan, Hugh, 1989, Vol. 03(4) pp. 3
Risch, Neil, 2000, Vol. 14(1) pp. 1
risperidone (Risperdal)
age of patient and weight gain, 1998, Vol. 12(3) pp. 1
for aggression, 1996, Vol. 10(2) pp. 2; 1996, Vol. 10(4) pp. 7; 1997, Vol. 11(2) pp. 6; 1998, Vol. 12(2) pp. 4; 1998, Vol. 12(3) pp. 1; 1999, Vol. 13(1) pp. 5; 2000, Vol. 14(2) pp. 5.
for agitation, 1997, Vol. 11(1) pp. 2; 2004, Vol. 18(4) pp. 4.
and amenorrhea, 1999, Vol. 13(4) pp. 4; 2001, Vol. 15(2) pp. 4.
for anxiety, 1997, Vol. 11(1) pp. 2; 1997, Vol. 11(2) pp. 7; 1998, Vol. 12(3) pp. 1.
appetite increase from, 1997, Vol. 11(3) pp. 2
for attention, 1997, Vol. 11(1) pp. 2
for behaviors, 1996, Vol. 10(2) pp. 2; 1997, Vol. 11(1) pp. 2; 1997, Vol. 11(2) pp. 6; 1998, Vol. 12(3) pp. 1.
and cardiac disorders, 2000, Vol. 14(1) pp. 5; 2001, Vol. 15(2) pp. 4; 2002, Vol. 16(4) pp. 6.
for children, 2000, Vol. 14(1) pp. 5
and depression, 1998, Vol. 12(3) pp. 1
and diabetes, 1999, Vol. 13(3) pp. 2; 2001, Vol. 15(4) pp. 5; 2002, Vol. 16(4) pp. 6; 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(2) pp. 2.
dosages, 1999, Vol. 13(2) pp. 6
drug interactions with, 1996, Vol. 10(2) pp. 2; 2002, Vol. 16(4) pp. 6.
dyskinesia from withdrawal from, 2002, Vol. 16(1) pp. 5
for eating disorders, 1996, Vol. 10(4) pp. 7
and haloperidol compared, 1995, Vol. 09(4) pp. 4; 1996, Vol. 10(2) pp. 2; 1998, Vol. 12(2) pp. 4.
for hyperactivity, 1998, Vol. 12(2) pp. 4; 2001, Vol. 15(2) pp. 4.
hyperprolactinemia from, 2001, Vol. 15(2) pp. 4; 2002, Vol. 16(4) pp. 6.
for irritability, 1998, Vol. 12(3) pp. 1; 2001, Vol. 15(2) pp. 4; 2004, Vol. 18(4) pp. 4.
and megacolon, 2003, Vol. 17(1) pp. 6
for mood swings, 1999, Vol. 13(1) pp. 5; 2001, Vol. 15(4) pp. 5.
and neuroleptic malignant syndrome, 1996, Vol. 10(3) pp. 2; 1997, Vol. 11(1) pp. 2.
for obsessive behaviors, 1997, Vol. 11(1) pp. 2; 1997, Vol. 11(2) pp. 7.
and obsessive-compulsive behavior, 1996, Vol. 10(3) pp. 6; 2003, Vol. 17(3) pp. 7.
osteoporosis from, 2001, Vol. 15(2) pp. 4
for perseveration, 1996, Vol. 10(2) pp. 2
for pervasive developmental disorders (PDD), 1994, Vol. 08(4) pp. 1
for self-injury, 1996, Vol. 10(2) pp. 2; 1997, Vol. 11(2) pp. 6.
side effects from, 1996, Vol. 10(2) pp. 2; 1998, Vol. 12(3) pp. 1; 2000, Vol. 14(3) pp. 4.
for sociability, 1996, Vol. 10(2) pp. 2; 1997, Vol. 11(1) pp. 2; 2001, Vol. 15(2) pp. 4.
tardive dyskinesia from, 2002, Vol. 16(4) pp. 6
for Tourette's, 1995, Vol. 09(4) pp. 4
and weight gain, 1998, Vol. 12(3) pp. 1; 2001, Vol. 15(4) pp. 5; 2004, Vol. 18(2) pp. 2.
and ziprazidone compared, 2004, Vol. 18(1) pp. 6
Ritalin. See methylphenidate (Ritalin)
ritualistic behaviors
ABA (Applied Behavior Analysis) for, 2002, Vol. 16(2) pp. 2
in catatonic autistics, 2000, Vol. 14(4) pp. 4
DAN! Protocol for, 1997, Vol. 11(1) pp. 6
diet for, 2002, Vol. 16(3) pp. 1
DMG for, 1992, Vol. 06(1) pp. 7
drugs (antidepressants) for, 1991, Vol. 05(4) pp. 1; 1992, Vol. 06(3) pp. 4; 1993, Vol. 07(4) pp. 1.
drugs (risperidone) for, 1996, Vol. 10(2) pp. 2; 1997, Vol. 11(2) pp. 6.
from PANDAS, 1998, Vol. 12(2) pp. 2
vitamin B6 for, 1991, Vol. 05(4) pp. 7; 1992, Vol. 06(2) pp. 6.
Ritvo, Edward R.
autosomal recessive model, 1997, Vol. 11(2) pp. 3
candida controversy, 1988, Vol. 02(4) pp. 6; 1989, Vol. 03(1) pp. 6.
employment prospects for autistics, 1990, Vol. 04(3) pp. 6
family rates of autism, 1989, Vol. 03(2) pp. 1; 1989, Vol. 03(4) pp. 5.
on fenfluramine, 1987, Vol. 01(3) pp. 1; 2002, Vol. 16(4) pp. 2.
MRI and cerebellar defects, 1988, Vol. 02(4) pp. 1
on normal autistics, 1988, Vol. 02(2) pp. 5
population rates of autism, 1989, Vol. 03(2) pp. 1
Purkinje cell findings, 1987, Vol. 01(1) pp. 1
retinal findings, 1987, Vol. 01(1) pp. 4
on retinoblastoma, 1989, Vol. 03(1) pp. 4
on savants, 1989, Vol. 03(1) pp. 2
Rivas, Wyatt H., 2004, Vol. 18(1) pp. 6; 2004, Vol. 18(4) pp. 4.
rivastigmine tartate (Excelon), 2004, Vol. 18(2) pp. 5
Robbins, Frank R., 1992, Vol. 06(1) pp. 5
Roberts, G.E., 1987, Vol. 01(4) pp. 3
Roberts, Hyman, 1992, Vol. 06(2) pp. 4
Robinson, Jennifer, 1994, Vol. 08(4) pp. 2
Rocha, Pedro Paulo, 1989, Vol. 03(4) pp. 2
rocking, 1992, Vol. 06(1) pp. 4; 2001, Vol. 15(3) pp. 5.
Rockwood Farm, 1994, Vol. 08(4) pp. 7
Rodier, Patricia, 1997, Vol. 11(3) pp. 1; 1998, Vol. 12(1) pp. 5.
Rodney King metaphor for deinstitutionalization, 1991, Vol. 05(3) pp. 3
Rodrigue, James, 1991, Vol. 05(3) pp. 6
Rodrigue, Vicki, 2000, Vol. 14(4) pp. 6
Rogers, Sally J., 1990, Vol. 04(1) pp. 4; 1995, Vol. 09(3) pp. 3.
Rolider, Amos, 1991, Vol. 05(4) pp. 5
Rollens, Rick, 1995, Vol. 09(2) pp. 7; 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(2) pp. 1; 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(3) pp. 2.
Romanczyk, Raymon, 1988, Vol. 02(4) pp. 2
room management, 1988, Vol. 02(3) pp. 5
Roseman, Bruce, 2000, Vol. 14(2) pp. 3
Rosencrans, John A., 1998, Vol. 12(4) pp. 2
Rosenhall, U., 1988, Vol. 02(4) pp. 4
Rosenthal, D., 1995, Vol. 09(1) pp. 4
Rosenthal-Malek, Andrea, 1997, Vol. 11(2) pp. 5
Rosner, M.H., 2004, Vol. 18(1) pp. 5
Rosse, R., 1997, Vol. 11(3) pp. 4
Rosseneu, Sophie, 2004, Vol. 18(3) pp. 3
rotavirus vaccine, 1999, Vol. 13(3) pp. 1
Rothman, Kenneth, 1995, Vol. 09(4) pp. 5
Rothschild, Jonathan, 1994, Vol. 08(3) pp. 2
Rowe, Katherine S. and Kenneth J., 1995, Vol. 09(2) pp. 5
Rowe and Rowe
RRTC (Research and Rehabilitation Training Center on Community-Referenced, Non-Aversive Behavior Management), 1988, Vol. 02(3) pp. 2, 6, 8
rubella, 1988, Vol. 02(3) pp. 4; 1995, Vol. 09(1) pp. 7; 1995, Vol. 09(4) pp. 3; 1998, Vol. 12(1) pp. 6; 1998, Vol. 12(3) pp. 3.
Rubin, Mark, 1997, Vol. 11(2) pp. 7
Ruch, Anne, 1990, Vol. 04(1) pp. 4
Rudick, Cameron, 2002, Vol. 16(2) pp. 7
Rudick, Jane, 1991, Vol. 05(1) pp. 1; 1992, Vol. 06(1) pp. 6; 1995, Vol. 09(2) pp. 2; 2002, Vol. 16(2) pp. 7.
rule-based strategies, 1987, Vol. 01(1) pp. 2; 1989, Vol. 03(1) pp. 2.
rule-based teaching, 2002, Vol. 16(3) pp. 5
Rumbaugh, Duane, 1988, Vol. 02(1) pp. 3; 1994, Vol. 08(4) pp. 3.
rumination, 1995, Vol. 09(1) pp. 5; 1995, Vol. 09(2) pp. 7.
Rumsey, Judith M.
rural alternative, 1990, Vol. 04(3) pp. 3; 1990, Vol. 04(4) pp. 7; 1991, Vol. 05(1) pp. 7; 1994, Vol. 08(4) pp. 7; 1995, Vol. 09(1) pp. 7; 1999, Vol. 13(2) pp. 7.
Rusch, F., 1990, Vol. 04(3) pp. 6
Ruschena, David, 2003, Vol. 17(4) pp. 5
Rush Epilepsy Center, 1997, Vol. 11(4) pp. 2
Rush-Presbyterian-St. Luke's Medical Center, 1991, Vol. 05(1) pp. 2
Rusty's Morningstar Ranch (Arizona), 1990, Vol. 04(3) pp. 3
Rutgers University, 1991, Vol. 05(4) pp. 5
Rutter, Michael, 1989, Vol. 03(2) pp. 2
Ryback, David, 1992, Vol. 06(3) pp. 3
Ryyanen, Markku, 1995, Vol. 09(3) pp. 1
© copyright 2005, 2006 Autism Research Institute
|
|
